Related references
Note: Only part of the references are listed.The quality of life in neoadjuvant versus adjuvant therapy of esophageal cancer treatment trial (QUINTETT): Randomized parallel clinical superiority trial
Richard A. Malthaner et al.
THORACIC CANCER (2022)
Adjuvant Nivolumab in Esophageal Cancer - A New Standard of Care
David H. Ilson
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis
Yiding Li et al.
BMC CANCER (2020)
Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries
Martin C. S. Wong et al.
SCIENTIFIC REPORTS (2018)
Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy
Weipeng Chen et al.
THORACIC CANCER (2018)
Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis
Jinxuan Hou et al.
ONCOTARGETS AND THERAPY (2018)
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Matthias Reeh et al.
ANNALS OF SURGERY (2015)
A Pilot Study Assessing the Incidence and Clinical Significance of Circulating Tumor Cells in Esophagogastric Cancers
Francesco Sclafani et al.
CLINICAL COLORECTAL CANCER (2014)
Detection and isolation of circulating tumor cells: Principles and methods
Hadi Esmaeilsabzali et al.
BIOTECHNOLOGY ADVANCES (2013)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
Circulating tumour cells in non-metastatic breast cancer: a prospective study
Anthony Lucci et al.
LANCET ONCOLOGY (2012)
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
A. Gradilone et al.
ANNALS OF ONCOLOGY (2011)
Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance
Yun-Fan Sun et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
Hisae Iinuma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2010)
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
J. Tol et al.
ANNALS OF ONCOLOGY (2010)
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
Panayiotis A. Theodoropoulos et al.
CANCER LETTERS (2010)
Post-Operative Extended Volume External Beam Radiation Therapy in High Risk Esophageal Cancer Patients: A Prospective Experience
Edward Yu et al.
Current Oncology (2010)
Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial.
B. K. Rack et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma
Andreas-Claudius Hoffmann et al.
PHARMACOGENOMICS (2010)
Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance
Mei Cao et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Circulating tumor cells in colorectal cancer:: correlation with clinical and pathological variables
J. Sastre et al.
ANNALS OF ONCOLOGY (2008)
Clinical Significance of Circulating Tumor Cells in Blood from Patients with Gastrointestinal Cancers
Kunihiko Hiraiwa et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Circulating tumor cells in breast cancer:: methodology and clinical repercussions
Joan Martel Gasent Blesa et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
Jean-Yves Pierga et al.
CLINICAL CANCER RESEARCH (2008)
Circulating micrometastases of esophageal cancer detected by carcinoembryonic antigen mRNA reverse transcriptase-polymerase chain reaction: clinical implications
T. Hashimoto et al.
DISEASES OF THE ESOPHAGUS (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer
T. Setoyama et al.
BRITISH JOURNAL OF SURGERY (2007)
Circulating tumor cells in perioperative esophageal cancer patients: Quantitative assay system and potential clinical utility
Zhian Liu et al.
CLINICAL CANCER RESEARCH (2007)
Statistical considerations for enumeration of circulating tumor cells
Arjan G. J. Tibbe et al.
CYTOMETRY PART A (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer
Steven J. Cohen et al.
CLINICAL COLORECTAL CANCER (2006)
Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients
N Dandachi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosis
J Kaganoi et al.
BRITISH JOURNAL OF SURGERY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer
PL Huang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer
S Nakashima et al.
SURGERY (2003)
Disseminated tumour cells - Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas
I Vogel et al.
VIRCHOWS ARCHIV (2001)
Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer:: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques
BM Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)